Parsons Erin

Parsons Erin is listed in filings as Director at Kiora Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through Apr 2, 2025, including purchase activity. Recent filings connect the profile to Kiora Pharmaceuticals, Inc. (KPRX) and Alimera Sciences, Inc. (ALIM). The current snapshot covers public activity from Jun 13, 2024 to Apr 2, 2025. Reported amounts are shown as $58.6K to $17.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.